Precigen, Inc. (PGEN)
4.47
+0.25
(+5.92%)
USD |
NASDAQ |
Nov 06, 16:00
4.47
0.00 (0.00%)
Pre-Market: 08:44
Precigen Debt to Equity Ratio : 1.177 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.177 |
| June 30, 2026 | 2.257 |
| March 31, 2026 | 4.855 |
| December 31, 2025 | 4.700 |
| September 30, 2025 | 2.345 |
| June 30, 2025 | -0.874 |
| March 31, 2025 | 0.3504 |
| December 31, 2024 | 0.0825 |
| September 30, 2024 | 0.1038 |
| June 30, 2024 | 0.1469 |
| March 31, 2024 | 0.0691 |
| December 31, 2023 | 0.0599 |
| September 30, 2023 | 0.0501 |
| June 30, 2023 | 0.0479 |
| March 31, 2023 | 0.1178 |
| December 31, 2022 | 0.4073 |
| September 30, 2022 | 0.6388 |
| June 30, 2022 | 3.734 |
| March 31, 2022 | 2.879 |
| December 31, 2021 | 1.771 |
| September 30, 2021 | 1.473 |
| June 30, 2021 | 1.20 |
| March 31, 2021 | 1.053 |
| December 31, 2020 | 2.714 |
| September 30, 2020 | 3.742 |
| Date | Value |
|---|---|
| June 30, 2020 | 5.027 |
| March 31, 2020 | 2.849 |
| December 31, 2019 | 3.244 |
| September 30, 2019 | 1.140 |
| June 30, 2019 | 0.9201 |
| March 31, 2019 | 0.83 |
| December 31, 2018 | 0.5847 |
| September 30, 2018 | 0.3409 |
| June 30, 2018 | 0.0152 |
| March 31, 2018 | 0.0149 |
| December 31, 2017 | 0.0155 |
| September 30, 2017 | 0.0156 |
| June 30, 2017 | 0.0153 |
| March 31, 2017 | 0.0159 |
| December 31, 2016 | 0.0157 |
| September 30, 2016 | 0.0149 |
| June 30, 2016 | 0.0137 |
| March 31, 2016 | 0.0136 |
| December 31, 2015 | 0.0131 |
| September 30, 2015 | 0.0133 |
| June 30, 2015 | 0.0218 |
| March 31, 2015 | 0.0162 |
| December 31, 2014 | 0.0329 |
| September 30, 2014 | 0.032 |
| June 30, 2014 | 0.0054 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics, Inc. | 0.1901 |
| Aldeyra Therapeutics, Inc. | 0.013 |
| Repligen Corp. | 0.3309 |
| AC Immune SA | 0.1166 |
| Inovio Pharmaceuticals, Inc. | 1.831 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 212.10M |
| Total Liabilities (Quarterly) | 128.31M |
| Shareholders Equity (Quarterly) | 83.79M |
| Current Ratio | 5.579 |
| Net Debt Paydown Yield | -0.61% |